Improving real-time MRI guidance for robotic-assisted treatments of abdominal cancers
New Technologies for Real-Time MRI-Guided Robotic-Assisted Abdominal Interventions
This study is working on new ways to use real-time MRI to help doctors perform safer and more effective robotic treatments for abdominal cancers, so patients can have less invasive procedures that protect healthy tissue and help them recover faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10894734 on NIH RePORTER |
What this research studies
This research focuses on developing new technologies that enhance the use of real-time MRI guidance during robotic-assisted interventions for abdominal cancers. By utilizing MRI, which does not involve ionizing radiation, the project aims to improve the visualization of cancerous lesions, making procedures like focal ablation more effective and safer for patients. The approach seeks to overcome the limitations of current imaging techniques, such as ultrasound and CT scans, which may not provide adequate guidance during interventions. Patients may benefit from less invasive procedures that preserve healthy tissue and reduce recovery time.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with abdominal cancers, particularly those with hepatocellular carcinoma or similar conditions requiring intervention.
Not a fit: Patients with non-abdominal cancers or those who are not candidates for surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatments for patients with abdominal cancers, potentially improving survival rates and quality of life.
How similar studies have performed: Previous research has shown promising results in using MRI for guiding interventions, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Wu, Holden H — University of California Los Angeles
- Study coordinator: Wu, Holden H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.